Clinical Report: Comprehensive Treatment Approaches for Advanced Bockenheimer Disease

Overview

This report details a case of a 14-year-old girl with late-stage Bockenheimer disease complicated by severe anemia and coagulopathy. Following a multimodal treatment approach, including sclerotherapy and anticoagulation, significant clinical improvement was observed after 9 months.

Background

Bockenheimer disease is a rare and complex venous malformation that can lead to significant morbidity, including pain, swelling, and hematologic complications. The management of this condition is challenging due to its progressive nature and the potential for severe complications during treatment. Understanding effective treatment strategies is crucial for improving patient outcomes.

Data Highlights

Key Findings

• A 14-year-old girl with late-stage Bockenheimer disease presented with severe anemia and coagulopathy.
• Initial treatment included anticoagulation therapy followed by sclerotherapy and local suture ligation.
• After 9 months, significant volume reduction in the affected limb and recovery of anemia were observed.
• Laboratory tests showed well-controlled coagulopathy post-treatment.
• Complications included contracture in the left elbow, highlighting the need for careful monitoring.

Clinical Implications

This case underscores the importance of a multimodal approach in managing Bockenheimer disease, particularly in patients with hematologic complications. Clinicians should be vigilant in monitoring hematologic profiles during treatment to mitigate risks associated with coagulopathy.

Conclusion

Reiterate the importance of early intervention with examples of potential complications.

References

1. Temple Health, Physician Resources, 2023 -- Advanced Diagnosis and Therapy for Paroxysmal Atrial Fibrillation and Chronic Blood Loss Anemia
2. Bone Marrow Transplantation, 2023 -- Management Strategies and Hematopoietic Stem Cell Transplantation for Aplastic Anemia
3. The ASCO Post, 2015 -- Microangiopathic Hemolytic Anemia and Thrombocytopenia Related Articles
4. International Society for the Study of Vascular Anomalies, 2024 -- Classification
5. PMC, 2024 -- Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients
6. Infection — Surprising Co-Infections Acquired in the Community During a Continuing Pandemic: An Overabundance of Concurrent Diagnoses
7. VASCA Patient Pathway for Venous Malformations
8. Classification | International Society for the Study of Vascular Anomalies
9. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients - PMC